|Budget Amount *help
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2011: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2010: ¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
We investigated gene therapy for pathological vascular remodeling targeting bone marrow-derived smooth muscle progenitor cells. In vitro study, green fluorescent protein(GFP) gene was transferred to COS-7 cells using sonoporation and the expression was confirmed by Western blotting and fluorescence microscopy. In vivo study, GFP gene was transferred to rat carotid artery and the gene expression was confirmed by fluorescence microscopy. We will prepare nano-bubbles and evaluate the further effects using a functional gene.